Catherine Mills

grad student

2018-

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
Mills CM, Benton TZ, Piña I, et al. (2023) Stimulation of natural killer cells with small molecule inhibitors of CD38 for the treatment of neuroblastoma. Chemical Science. 14: 2168-2182
Mills CM, Turner J, Piña IC, et al. (2022) Synthesis and evaluation of small molecule inhibitors of LSD1 for use against MYCN-expressing neuroblastoma. European Journal of Medicinal Chemistry. 244: 114818
Reader J, Opperman D, van der Watt M, et al. (2022) New Transmission-Selective Antimalarial Agents through Hit-To-Lead Optimization of 2-([1,1'-biphenyl]-4-carboxamido)benzoic acid Derivatives. Chembiochem : a European Journal of Chemical Biology
Beck TC, Springs K, Morningstar JE, et al. (2022) Application of Pharmacokinetic Prediction Platforms in the Design of Optimized Anti-Cancer Drugs. Molecules (Basel, Switzerland). 27
Heslop KA, Burger P, Kappler C, et al. (2022) Small molecules targeting the NADH-binding pocket of VDAC modulate mitochondrial metabolism in hepatocarcinoma cells. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 150: 112928
Benton TZ, Mills CM, Turner JM, et al. (2021) Selective targeting of CD38 hydrolase and cyclase activity as an approach to immunostimulation. Rsc Advances. 11: 33260-33270